Form C - Offering Statement:
SEC Accession No. 0001665160-24-000283
Filing Date
2024-03-28
Accepted
2024-03-28 09:17:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9414
2 offeringmemoformc.pdf EX-99 24619781
  Complete submission text file 0001665160-24-000283.txt   33915935
Mailing Address 1600 FAIRVIEW AVENUE EAST SUITE 300 SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVENUE EAST SUITE 300 SEATTLE WA 98102 2144788208
Deverra Therapeutics, Inc. (Filer) CIK: 0001822782 (see all company filings)

EIN.: 843312665 | State of Incorp.: DE
Type: C | Act: 33 | File No.: 020-33895 | Film No.: 24793933